financetom
Business
financetom
/
Business
/
Salesforce Insider Sold Shares Worth $4,064,172, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce Insider Sold Shares Worth $4,064,172, According to a Recent SEC Filing
Apr 22, 2024 3:03 PM

05:54 PM EDT, 04/22/2024 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on April 19, 2024, sold 15,000 shares in Salesforce ( CRM ) for $4,064,172. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,827,327 shares of the company, with 12,827,327 shares held directly and 10,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1108524/000112760224013245/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gold Reserve Provides Update On CITGO Sale Process
Gold Reserve Provides Update On CITGO Sale Process
Aug 26, 2025
09:27 AM EDT, 08/26/2025 (MT Newswires) -- Gold Reserve ( GDRZF ) , which lost more than 5% on Monday, said that pursuant to the schedule set by the U.S. District Court for the District of Delaware, the Special Master provided a Notice of Determination of Superior Proposal. The company on Tuesday said the notice refers to an unsolicited competing...
Veracyte Completes Enrollment for Clinical Utility Trial to Evaluate Nasal Swab Lung Cancer Test
Veracyte Completes Enrollment for Clinical Utility Trial to Evaluate Nasal Swab Lung Cancer Test
Aug 26, 2025
09:29 AM EDT, 08/26/2025 (MT Newswires) -- Veracyte ( VCYT ) said Tuesday that it has reached its target enrollment for a clinical utility trial evaluating its Percepta Nasal Swab test. The cancer diagnostics company said the trial has now enrolled 2,400 patients at more than 90 academic and community centers across the US. The test is used to assess...
AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
Aug 26, 2025
AbbVie Inc. ( ABBV ) announced Monday that it will acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate for moderate-to-severe major depressive disorder (MDD). The deal, valued at up to $1.2 billion, includes an upfront payment and development milestones for the bretisilocin program. As part of the transaction, Gilgamesh will spin off a new entity, Gilgamesh Pharma Inc., to manage its...
Natural Gas Edges Up From 10-Month Low Despite Cool Forecasts
Natural Gas Edges Up From 10-Month Low Despite Cool Forecasts
Aug 26, 2025
09:26 AM EDT, 08/26/2025 (MT Newswires) -- Natural gas rose off its lowest in nearly 10 months early on Tuesday even as long-term forecasts see cool temperatures coming for most states, cutting into air-conditioning demand. Gas for September delivery was last seen up US$0.01 to US$2.71 per million British thermal units, after falling to the lowest since Nov. 8 a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved